[A Case of HER2-Positive Breast Cancer with Liver Metastases Showing Three Years of Complete Response to Combination Therapy with Trastuzumabplus Pertuzumab].
2018 · PubMed · 1 citations
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
243
Citations
6
h-index
6
i10-index
Yuri Fujimoto is an academic researcher from Kyushu University. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Adipose Tissue and Metabolism. The author has an h-index of 6, co-authored 14 publications.
ORCID: 0000-0001-5346-160Xhttps://doi.org/10.1186/s40981-020-00407-7
Click to start Chat